Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;56(9):3047-3055.
doi: 10.1007/s11255-024-04056-y. Epub 2024 Apr 20.

Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study

Min Rui #  1 , Lei Jiang #  2 , Jia-Jun Pan #  3 , Xue-Ting Huang #  4 , Jia-Fang Cui  4 , Shi-Jia Zhang  4 , Su-Mei He  5 , Huan-Huan Han  6 , Xiao Chen  7 , Dong-Dong Wang  8
Affiliations

Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study

Min Rui et al. Int Urol Nephrol. 2024 Sep.

Abstract

Purpose: The present study aims to explore the effects of tacrolimus on proteinuria in patients with idiopathic membranous nephropathy (IMN) and recommend an appropriate dosage schedule via machine learning method.

Methods: The Emax model was constructed to analyze the effects of tacrolimus on proteinuria in patients with IMN. Data were mined from published literature and machine learning was built up with Emax model, among which the efficacy indicator was proteinuria change rates from baseline. 463 IMN patients were included for modeling, and tacrolimus therapeutic window concentrations were 4-10 ng/ml.

Results: In machine learning model, the Emax from tacrolimus effecting proteinuria in IMN patients was -72.7%, the ET50 was 0.43 months, and the time to achieving 25% Emax, 50% Emax, 75% Emax, and 80% (plateau) Emax of tacrolimus on proteinuria in patients with IMN were 0.15, 0.43, 1.29, and 1.72 months, respectively.

Conclusion: For achieving better therapeutic effects from tacrolimus on proteinuria in patients with IMN, tacrolimus concentration range need to be maintained at 4-10 ng/ml for at least 1.72 months.

Keywords: Idiopathic membranous nephropathy; Machine learning; Prediction; Proteinuria; Tacrolimus.

PubMed Disclaimer

References

    1. Beck LH Jr, Salant DJ (2014) Membranous nephropathy: from models to man. J Clin Investig 124(6):2307–2314. https://doi.org/10.1172/JCI72270 - DOI - PubMed - PMC
    1. Huang H, Liang Z, Zheng X, Qing Q, Du X, Tang Z et al (2021) Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials. Ren Fail 43(1):840–850. https://doi.org/10.1080/0886022X.2021.1914655 - DOI - PubMed - PMC
    1. Zhang XD, Cui Z, Zhang MF, Wang J, Zhang YM, Qu Z et al (2018) Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol 19(1):215. https://doi.org/10.1186/s12882-018-1011-5 - DOI - PubMed - PMC
    1. Polanco N, Gutierrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D et al (2012) Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transpl 27(1):231–234. https://doi.org/10.1093/ndt/gfr285 - DOI
    1. Hladunewich MA, Troyanov S, Calafati J, Cattran DC (2009) The natural history of the non nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol CJASN 4(9):1417–1422. https://doi.org/10.2215/CJN.01330209 - DOI - PubMed

Supplementary concepts

LinkOut - more resources